By Adam Bonislawski

This article was originally posted on June 14.

Two separate mass spec screens of the mTOR-regulated phosphoproteome – one led by researchers at Harvard University and the other by scientists at the Massachusetts Institute of Technology – have offered new insights into the workings of the far-reaching but poorly understood signaling network.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.